Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome
β Scribed by Gallardo, M.; Post, S.M.
- Book ID
- 123257094
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 61 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1043-321X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The tumor suppressor TP53 pathway plays a crucial role in preventing carcinogenesis through its ability to impose cell cycle arrest and apoptosis following DNA damage and oncogene activation. MDM2 is a key negative regulator of the TP53 pathway and is overexpressed in many cancers as oncoprotein. We
We examined the association between mutation of the p53 gene and survival in a large cohort of breast cancer patients. Using a rapid, non-isotopic single-strand conformation polymorphism (SSCP) method we screened for mutations in exons 4-10 of the p53 gene in 375 primary breast cancers from patients